Botox (onabotulinum toxin A) has emerged as a life changing treatment for patients with bladder and pelvic floor dysfunction. This presentation covers indications and success rates for botox applications in use and in development including neurogenic bladder, idiopathic overactive bladder, painful bladder syndrome, pelvic floor muscle dysfunction and chronic prostatitis.
Contact hours available until 3/7/2015.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure:
Planning Committee Disclosures:
Donna J. Carrico, WHNP, MS/ Consultant/Presenter Bureau: Uroplasty Inc.
Speaker Disclosures: Sophie G. Fletcher, MD has disclosed the following relevant relationships with commercial interests: Grant/Research Support: K12DK093014 Consultant/Presenter Bureau: Trophikos Inc, Coloplast
There are no other disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Non-Endorsement of Products: Accreditation of activities for contact hours does not imply approval or endorsement of any product, advertising, or educational content by the Society of Urologic Nurses and Associates (SUNA) or the American Nurses Credentialing Center’s Commission on Accreditation.
Accreditation Statement: Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Accreditation status does not imply endorsement by the provider or ANCC of any commercial product.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Recognize how Botox works in the bladder.
Identify the patient population that best benefit from Botox Bladder Injections.
Outline FDA recommendations for the safe handling of Botox, and the restricted patient population it is recommended for.
Identify complications related to Botox Bladder Injection.